Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4210
Gene Symbol: MEFV
MEFV
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Pop-eyelid and eyelash ptosis were observed in 8% of patients operated with FMF. 29659435

2019

Entrez Id: 7471
Gene Symbol: WNT1
WNT1
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Thorough revision of the clinical symptoms of these 10 novel patients and previously published AR WNT1 OI cases highlight ptosis as a unique hallmark in the diagnosis of this OI subtype. 30896082

2019

Entrez Id: 146
Gene Symbol: ADRA1D
ADRA1D
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Because apraclonidine has an α-1 agonistic effect, α-1D adrenoceptor may contribute to apraclonidine's elevating effect in patients with blepharoptosis. 29634605

2019

Entrez Id: 4566
Gene Symbol: TRNK
TRNK
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE The first patient, a 44-year-old woman, had bilateral eyelid ptosis and the m.8305C>T mutation in the MTTK gene. 29174468

2018

Entrez Id: 4810
Gene Symbol: NHS
NHS
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE PurposeCorrection of upper eyelid ptosis is one of the most commonly performed oculoplastic procedures on the NHS but there is currently no data in the literature informing the surgeon of the optimal time for the first postoperative review. 29328065

2018

Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Effects of MALAT1 on proliferation and apo- ptosis of human non-small cell lung cancer A549 cells in vitro and tumor xenograft growth in vivo by modulating autophagy. 29439314

2018

Entrez Id: 4128
Gene Symbol: MAOA
MAOA
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 AlteredExpression BEFREE In addition, IRN treatment antagonized reserpine-induced ptosis and significantly enhanced the levels of monoamine neurotransmitters including norepinephrine (NE) and 5-hydroxytryptamine (5-HT), and the activity of monoamine oxidase A (MAO-A) in the hippocampus and frontal cortex of mice. 27900600

2017

Entrez Id: 5617
Gene Symbol: PRL
PRL
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE In vivo studies measuring ptosis and prolactin secretion in the rat confirmed the specific and dose-dependent interactions of tetrabenazine and R,R,R-HTBZ with VMAT2. 28404690

2017

Entrez Id: 27335
Gene Symbol: EIF3K
EIF3K
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Two months after delivery, the mother developed ptosis and generalized symptoms and subsequent workup revealed she was muscle specific kinase (MuSK) antibody positive. 28495046

2017

Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE We propose that the PIK3CB gene included in our patient's chromosome 3q deletion may be the gene responsible for microcephaly and other patients with blepharophimosis-ptosis-epicanthus inversus syndrome because of a chromosome 3q deletion. 24725350

2014

Entrez Id: 57132
Gene Symbol: CHMP1B
CHMP1B
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE Although the incidental association of OT and C10orf2 TWINKLE mutation is possible, the simultaneous onset of OT and eyelid ptosis at a much younger age than usually observed for OT raises the possibility of mitochondrial dysfunction and loss of mitochondrial DNA integrity in the pathogenesis of OT. 24061067

2013

Entrez Id: 9048
Gene Symbol: ARTN
ARTN
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE We demonstrate its use in identifying ARTN as a strong candidate gene within the 1p34.1-p32 mapped locus for a hereditary form of ptosis. 22331800

2012

Entrez Id: 84107
Gene Symbol: ZIC4
ZIC4
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE De novo interstitial deletion of 3q22.3-q25.2 encompassing FOXL2, ATR, ZIC1, and ZIC4 in a patient with blepharophimosis/ptosis/epicanthus inversus syndrome, Dandy-Walker malformation, and global developmental delay. 21471554

2011

Entrez Id: 79776
Gene Symbol: ZFHX4
ZFHX4
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 Biomarker BEFREE Human ZFH-4 is therefore a candidate gene for congenital bilateral isolated ptosis. 11935336

2002

Entrez Id: 401
Gene Symbol: PHOX2A
PHOX2A
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE (4,5) Individuals with CFEOM2 are born with bilateral ptosis and exotropia. 11960793

2002

Entrez Id: 2181
Gene Symbol: ACSL3
ACSL3
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.010 GeneticVariation BEFREE Saethre-Chotzen syndrome (acrocephalo-syndactyly type III, ACS III) is an autosomal dominant craniosynostosis with brachydactyly, soft tissue syndactyly and facial dysmorphism including ptosis, facial asymmetry and prominent ear crura. 8988167

1997

Entrez Id: 4974
Gene Symbol: OMG
OMG
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.020 GeneticVariation BEFREE Twenty-two patients with OMG presenting with isolated ptosis or diplopia, who initially tested negative, were re-tested in relation to a worsening of their symptoms showing a positivisation in 91% of cases. 31734908

2020

Entrez Id: 4974
Gene Symbol: OMG
OMG
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.020 Biomarker BEFREE Most patients first present with extraocular symptoms (diplopia and/or ptosis), and in 15% of cases symptoms will remain restricted to only the extraocular muscles (ocular myasthenia gravis [OMG]). 31847046

2019

Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.040 GeneticVariation BEFREE We report familial segregation of hereditary total leuconychia (HTL) with ptosis and restriction of ocular motility due to congenital fibrosis of the extraocular muscles type 1 (CFEOM1) in three generations. 19489868

2009

Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.040 AlteredExpression BEFREE Four families were clinically classified as having CFEOM type 1 (CFEOM1) with full expression of severe ptosis and ophthalmoplegia. 18332320

2008

Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.040 Biomarker BEFREE Subjects with CFEOM1 had severe bilateral blepharoptosis, limited supraduction, and variable ophthalmoplegia. 15671279

2005

Entrez Id: 55605
Gene Symbol: KIF21A
KIF21A
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.040 Biomarker BEFREE Individuals with CFEOM1 are born with bilateral ptosis and both eyes fixed in a downward position with absent upgaze and aberrant horizontal gaze. 11960793

2002

Entrez Id: 55777
Gene Symbol: MBD5
MBD5
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.090 Biomarker BEFREE Secondary outcome was overall mean change in MRD1 and the incidence of ptosis as defined by a final MRD1 ≤ 2.5 mm. 30908469

2020

Entrez Id: 9904
Gene Symbol: RBM19
RBM19
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.090 Biomarker BEFREE Secondary outcome was overall mean change in MRD1 and the incidence of ptosis as defined by a final MRD1 ≤ 2.5 mm. 30908469

2020

Entrez Id: 55777
Gene Symbol: MBD5
MBD5
CUI: C0005745
Disease: Blepharoptosis
Blepharoptosis
0.090 Biomarker BEFREE Mechanical (involuntary) brow elevation significantly raised MRD1 in control eyelids and eyelids with dermatochalasis, but not in eyelids with ptosis. 30124610

2019